References
Niranjan A, Lunsford LD (2000) Radiosurgery: where we were, are and may be in the next millennium. Neurosurgery 46:531–543
Kondziolka D, Levy E, Niranjan A, et al. (1999) Long-term outcomes after meningioma radiosurgery: the physician and patients' perspective. J Neurosurg 91:44–50
Shafron DH, Friedman WA, Buatti JM, et al. (1999) Linac radiosurgery for benign meningiomas. Int J Radiat Oncol Biol Phys 43:321–327
Kobayashi T, Tanaka T, Kida Y (1994) The early effects of gamma knife on 40 cases of acoustic neuroma. Acta Neurochir Suppl (Wien) 62:93–97
Kondziolka D, Lunsford LD, McLaughlin M, et al. (1998) Long-term outcome after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433
Niranjan A, Lunsford LD, Flickinger JC, et al. (1999) Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery. Neurosurgery 45:753–765
Alexander E III, Loeffler JS (1999) The role of radiosurgery for glial neoplasms. Neurosurg Clin North Am 10:351–358
Mehta MP (1997) Radiosurgery of malignant brain tumors. In: de Salles AAF, Lufkin RB (eds) Minimally invasive therapy of the brain. Thieme, New York, pp 213–224
Kondziolka D, Flickinger JC, Bissonette DJ, et al. (1997) Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41:776–785
Sarkaria JN, Mehta MP, Loeffler JS, et al. (1995) Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 32:931–941
Alexander E III, Loffler JS (1998) Radiosurgery for primary malignant brain tumors. Semin Surg Oncol 14:43–52
Loeffler JS, Alexander E III, Shea WM, et al. (1992) Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10:1379–1385
Foote KD, Friedman WA, Buatti JM, et al. (1999) Linear accelerator radiosurgery in brain tumor management. Neurosurg Clin North Am 10:203–242
Borgelt B, Gelber R, Kramer S, et al. (1980) The palliation of brain metastases. Final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–8
Diener-West M, Dobbins TW, Phillips TL, et al. (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673
Patchell RA, Tibbs PA, Walsh JW, et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500
Kihlström L, Karlsson B, Lindquist C (1993) Gamma knife surgery for cerebral metastases. Implications for surviyal based on 16-year experience. Stereotact Funct Neurosurg 61 (Suppl): 45–55
Alexander E III, Moriarty TM, Davis RB, et al. (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Int 87:34–40
Flickinger JC, Kondziolka D, Lunsford LD, et al. (1994) A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastases. Int J Radiat Oncol Biol Phys 28:797–802
Fukuoka S, Seo Y, Takanashi M, et al. (1996) Radiosurgery of brain metastases with the gamma knife. Stereotact Funct Neurosurg 66 (Suppl 1):193–200
Gerosa M, Nicolato A, Severi F, et al. (1996) Gamma knife radiosurgery for intracranial metastases: from local tumor control to increased survival. Stereotact Funct Neurosurg 66 (Suppl 1): 184–192
Shiau CY, Sneed PK, Shu HK, et al. (1997) Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37:375–383
Oldfield EH, Friedman R, Kinsella T, et al. (1990) Reduction in radiation-induced brain injury by use of pentobarbitol or lidocain protection. J Neurosurg 72:737–744
Kondziolka D, Somaza S, Flickinger JC, et al. (1994) Cerebral radioprotective effects of high-dose pentobarbital evaluated in an animal radiosurgery model. Neurol Res 16:456–459
Smith SL, Scherch HM, Hall ED (1996) Protective effects of tirilazads mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxydative neuronal injury. J Neurosurg 84:229–233
Braughler JM (1985) Lipid peroxidation-induced inhibition of gamma-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J Neurochem 44:1282–1288
Hall ED (1993) Lipid antioxidants in acute cerebral nervous system injury. Ann Emerg Med 22:1022–1027
Bernstein M, Ginsburg H, Glen J (1992) Protection of iodine-125 brachy-therapy brain injury in the rat with 21 aminosteroid U-74389G. Neurosurgery 31:923–928
Buatti JM, Friedman WA, Theele DP, et al. (1996) The lazaroid U-74389G protects normal brain from stereotactic radiosurgery-induced radiation injury. Int J Radiat Oncol Biol Phys 34:591–597
Kondziolka D, Somaza S, Martinez AJ, et al. (1997) Radioprotective effects of 21 aminosteroid U-74389G for stereotactic radiosurgery. Neurosurgery 41:203–208
Staba MJ, Mauceri HJ, Kufe DW, et al. (1998) Adenoviral TNF-α gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Ther 5:293–300
Cao G, Kuriyama S, Du P, et al. (1997) Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor-α gene transfer. Gastroenterology 11:270–278
Han SK, Brody SL, Crystal RG (1994) Suppression of in vivo tumorigenicity of human lung cancer cells by retrovirus-mediated transfer of the human tumor necrosis factor-alpha cDNA. Am J Resp Cell Mol Biol 11:270–278
Ostensen ME, Thiele DL, Lipsky PE (1987) Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2. J Biol Res Mod 8:53–61
Owen-Schaub LB, Gutterman JU, Grimm EA (1988) Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res 48:788–792
Pfizenmaier K, Scheurich P, Schluter C, et al. (1987) Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J Immunol 138:975–980
Plaetinck G, Declercq W, Tavernier J, et al. (1987) Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat × mouse T cell hybrid. Eur J Immunol 17:1835–1838
Ranges GE, Figari IS, Espevik T, et al. (1987) Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166:991–998
Gridley DS, Archambeau JO, Andres, et al. (1997) Tumor necrosis factor-α enhances antitumor effect of radiation against glioma xenograft. Oncol Res 9:217–227
Niranjan A, Moriuchi S, Lunsford LD, et al. (2000) Effective treatment of experimental gliobalstoma by TNF-α and HSV-tk gene transfer in combination with radosurgery and ganciclovir administration. Mol Ther 2:114–120
Marconi P, Tamura M, Moriuchi S, et al. (2000) Connexin 43-enhanced suicide gene therapy using herpesviral vectors. Mol Ther 1:71–81
Moriuchi S, Oligino T, Krisky D, et al. (1998) Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-α and herpes simplex virus thymidine kinase. Cancer Res 58:5731–5737
Lynch WP, Sharpe AH, Snyder EY (1999) Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J Virol 73:6841–6851
Frisen J, Johansson CB, Lothian C, et al. (1999) Central nervous system stem cells in the embryo and adult. Cell Mol Life Sci 54:935–945
Weiss S, Dunne C, Hewson J, et al. (1996) Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci 16:7599–7609
Weiss S, Reynolds BA, Vescovi AL, et al. (1996) Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 19:387–393
Yandava BD, Billinghurst LL, Snyder EY (1999) “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 96:7029–7034
Hammang JP, Archer DR, Duncan ID (1997) Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment. Exp Neurol 147:84–95
Flax JD, Aurora S, Yang C, et al. (1998) Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nature Biotechnol 16:1033–1039
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niranjan, A., Lunsford, L.D., Gobbel, G.T. et al. Brain tumor radiosurgery: current status and strategies to enhance the effect of radiosurgery. Brain Tumor Pathol 17, 89–96 (2000). https://doi.org/10.1007/BF02482741
Issue Date:
DOI: https://doi.org/10.1007/BF02482741